Health
Cause of mystery illness revealed for 27 runners in Santa Barbara half-marathon
By Tom Langston
Experimental cancer drug: UH Rainbow researcher coauthors promising study
Michelle Rivera
Michelle Rivera
Reporter · Cleveland, OH
Michelle, an Ohio State University graduate, has spent over six years focusing on community issues in Cleveland, including social justice and local initiatives. She has previously written for NPR's local affiliates, where she honed her storytelling skills to highlight diverse community voices.
More from Michelle →Reporter · Tuesday, November 10, 2026 at 12:00 PM · 1 min read
CLEVELAND, Ohio — A physician researcher at University Hospitals Rainbow Babies Children’s Hospital has coauthored a new paper suggesting that an experimental drug may be able to eliminate 75% of aggressive tumors and fight tumors that were resistant to immunotherapy, UH said.
Up nextCause of mystery illness revealed for 27 runners in Santa Barbara half-marathonHealth · 1 min read
